236 related articles for article (PubMed ID: 29310594)
1. The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections.
Babikir IH; Abugroun EA; Bilal NE; Alghasham AA; Abdalla EE; Adam I
BMC Infect Dis; 2018 Jan; 18(1):17. PubMed ID: 29310594
[TBL] [Abstract][Full Text] [Related]
2. Role of urinary cathelicidin LL-37 and human β-defensin 1 in uncomplicated Escherichia coli urinary tract infections.
Nielsen KL; Dynesen P; Larsen P; Jakobsen L; Andersen PS; Frimodt-Møller N
Infect Immun; 2014 Apr; 82(4):1572-8. PubMed ID: 24452682
[TBL] [Abstract][Full Text] [Related]
3. Host Cathelicidin Exacerbates Group B
Patras KA; Coady A; Babu P; Shing SR; Ha AD; Rooholfada E; Brandt SL; Geriak M; Gallo RL; Nizet V
mSphere; 2020 Apr; 5(2):. PubMed ID: 32321824
[TBL] [Abstract][Full Text] [Related]
4. The Association between Serum 25-Hydroxy Vitamin D Level and Urine Cathelicidin in Children with a Urinary Tract Infection.
Övünç Hacıhamdioğlu D; Altun D; Hacıhamdioğlu B; Çekmez F; Aydemir G; Kul M; Müftüoğlu T; Süleymanoğlu S; Karademir F
J Clin Res Pediatr Endocrinol; 2016 Sep; 8(3):325-9. PubMed ID: 27180947
[TBL] [Abstract][Full Text] [Related]
5. Secretory leukocyte protease inhibitor protects against severe urinary tract infection in mice.
Rosen AL; Lint MA; Voelker DH; Gilbert NM; Tomera CP; Santiago-Borges J; Wallace MA; Hannan TJ; Burnham C-AD; Hultgren SJ; Kau AL
mBio; 2024 Feb; 15(2):e0255423. PubMed ID: 38270443
[TBL] [Abstract][Full Text] [Related]
6. Ribonuclease 7 Shields the Kidney and Bladder from Invasive Uropathogenic
Eichler T; Bender K; Murtha MJ; Schwartz L; Metheny J; Solden L; Jaggers RM; Bailey MT; Gupta S; Mosquera C; Ching C; La Perle K; Li B; Becknell B; Spencer JD
J Am Soc Nephrol; 2019 Aug; 30(8):1385-1397. PubMed ID: 31239387
[TBL] [Abstract][Full Text] [Related]
7. A Prospective, Observational Pilot Study of the Use of Urinary Antimicrobial Peptides in Diagnosing Emergency Department Patients With Positive Urine Cultures.
Caterino JM; Hains DS; Camargo CA; Quraishi SA; Saxena V; Schwaderer AL
Acad Emerg Med; 2015 Oct; 22(10):1226-30. PubMed ID: 26375724
[TBL] [Abstract][Full Text] [Related]
8. Role of uropathogenic Escherichia coli OmpT in the resistance against human cathelicidin LL-37.
Brannon JR; Thomassin JL; Desloges I; Gruenheid S; Le Moual H
FEMS Microbiol Lett; 2013 Aug; 345(1):64-71. PubMed ID: 23710656
[TBL] [Abstract][Full Text] [Related]
9. Virulence factors of uropathogenic Escherichia coli of urinary tract infections and asymptomatic bacteriuria in children.
Yun KW; Kim HY; Park HK; Kim W; Lim IS
J Microbiol Immunol Infect; 2014 Dec; 47(6):455-61. PubMed ID: 24064288
[TBL] [Abstract][Full Text] [Related]
10. Establishment of Baseline Urinary Antimicrobial Peptide Levels by Age: A Prospective Observational Study.
Caterino JM; Stephens JA; Wexler R; Camargo CA; Hunold KM; Wei L; Hains D; Southerland LT; Bischof JJ; Schwaderer A
J Gerontol A Biol Sci Med Sci; 2024 Jun; 79(6):. PubMed ID: 37708314
[TBL] [Abstract][Full Text] [Related]
11. Distribution of virulence genes and phylogenetics of uropathogenic Escherichia coli among urinary tract infection patients in Addis Ababa, Ethiopia.
Dadi BR; Abebe T; Zhang L; Mihret A; Abebe W; Amogne W
BMC Infect Dis; 2020 Feb; 20(1):108. PubMed ID: 32033541
[TBL] [Abstract][Full Text] [Related]
12. Single clinical isolates from acute uncomplicated urinary tract infections are representative of dominant in situ populations.
Willner D; Low S; Steen JA; George N; Nimmo GR; Schembri MA; Hugenholtz P
mBio; 2014 Feb; 5(2):e01064-13. PubMed ID: 24570371
[TBL] [Abstract][Full Text] [Related]
13. Urinary tract infections and antimicrobial sensitivity among diabetic patients at Khartoum, Sudan.
Hamdan HZ; Kubbara E; Adam AM; Hassan OS; Suliman SO; Adam I
Ann Clin Microbiol Antimicrob; 2015 Apr; 14():26. PubMed ID: 25896611
[TBL] [Abstract][Full Text] [Related]
14. Virulence genes and phylogenetic groups of uropathogenic Escherichia coli isolates from patients with urinary tract infection and uninfected control subjects: a case-control study.
Rezatofighi SE; Mirzarazi M; Salehi M
BMC Infect Dis; 2021 Apr; 21(1):361. PubMed ID: 33865334
[TBL] [Abstract][Full Text] [Related]
15. Multilocus sequence typing of Escherichia coli isolates from urinary tract infection patients and from fecal samples of healthy subjects in a college community.
Matsui Y; Hu Y; Rubin J; de Assis RS; Suh J; Riley LW
Microbiologyopen; 2020 Jun; 9(6):1225-1233. PubMed ID: 32189451
[TBL] [Abstract][Full Text] [Related]
16. Polysaccharides extract from Vaccaria segetalis seeds inhibits kidney infection by regulating cathelicidin expression.
Mao X; Yao R; Guo H; Bao L; Bao Y; Xu Y; Sun J; Guo S; Shi Y; Liu S; Zhang H; Cui X
J Ethnopharmacol; 2021 Mar; 267():113505. PubMed ID: 33141055
[TBL] [Abstract][Full Text] [Related]
17. Cathelicidin augments epithelial receptivity and pathogenesis in experimental Escherichia coli cystitis.
Danka ES; Hunstad DA
J Infect Dis; 2015 Apr; 211(7):1164-73. PubMed ID: 25336727
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D induction of the human antimicrobial Peptide cathelicidin in the urinary bladder.
Hertting O; Holm Å; Lüthje P; Brauner H; Dyrdak R; Jonasson AF; Wiklund P; Chromek M; Brauner A
PLoS One; 2010 Dec; 5(12):e15580. PubMed ID: 21179490
[TBL] [Abstract][Full Text] [Related]
19. Expression and Significance of the HIP/PAP and RegIIIγ Antimicrobial Peptides during Mammalian Urinary Tract Infection.
Spencer JD; Jackson AR; Li B; Ching CB; Vonau M; Easterling RS; Schwaderer AL; McHugh KM; Becknell B
PLoS One; 2015; 10(12):e0144024. PubMed ID: 26658437
[TBL] [Abstract][Full Text] [Related]
20. The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection.
Chromek M; Slamová Z; Bergman P; Kovács L; Podracká L; Ehrén I; Hökfelt T; Gudmundsson GH; Gallo RL; Agerberth B; Brauner A
Nat Med; 2006 Jun; 12(6):636-41. PubMed ID: 16751768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
